Header cover image

Polish (WIG) Biotech Industry Analysis

UpdatedJan 21, 2022
DataAggregated Company Financials
  • 7D-2.0%
  • 3M-19.7%
  • 1Y-3.8%
  • YTD-1.3%

Over the last 7 days, the Biotech industry has dropped 2.7%, driven by a pullback from Mabion of 7.3%. However, the industry is down 5.2% over the past year.

Industry Valuation and Performance

Has the Polish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 21 Jan 2022zł3.6bzł369.9m-zł24,922,742.0048.1x
Sun, 19 Dec 2021zł3.9bzł369.9m-zł24,922,742.0049.2x
Tue, 16 Nov 2021zł3.6bzł367.1mzł91,715.0035.1x
Thu, 14 Oct 2021zł3.7bzł364.5m-zł1,455,285.0033.3x
Sat, 11 Sep 2021zł3.5bzł364.5m-zł1,456,285.0037.7x
Mon, 09 Aug 2021zł3.6bzł362.9m-zł8,912,285.0040.5x
Sun, 02 May 2021zł3.8bzł373.1m-zł6,705,220.00122x
Wed, 03 Feb 2021zł1.6bzł382.5mzł56.4m110.3x
Sat, 07 Nov 2020zł2.1bzł307.0m-zł7,012,804.0059.4x
Fri, 31 Jul 2020zł2.5bzł289.2m-zł30,736,114.0037.7x
Mon, 04 May 2020zł851.1mzł304.1m-zł149,014,103.0047.7x
Thu, 06 Feb 2020zł581.0mzł295.6m-zł128,943,953.0036.7x
Sun, 10 Nov 2019zł592.9mzł300.9m-zł129,547,264.0028.2x
Sat, 03 Aug 2019zł1.9bzł302.3m-zł201,837,301.0031.6x
Tue, 07 May 2019zł1.6bzł308.2m-zł27,971,600.0017.1x
Fri, 08 Feb 2019zł1.6bzł316.8m-zł76,312,329.0016.7x
PE Ratio


Total Market Cap: zł1.6bTotal Earnings: -zł76,312,329.00Total Revenue: zł316.8m0%0%0%3 Year10 Year

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 47.8x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Biotechs industry have improved over the last three years, and revenues for these companies have grown 5.3% per year. This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Polish Biotech industry?


Industry PE: Investors are most optimistic about the Biotech industry, which is trading close to its 3-year average PE ratio of 47.8x. However analysts are expecting annual earnings growth of 69%, which is lower than the prior year's growth of 106% per year. So the market might believe that analysts are underestimating future growth.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 69% over the next 5 years. However this is lower than its past earnings growth rate of 106% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CTX Captor Therapeutics spolka akcyjnazł184.002.2%
BLR BLIRTzł9.9610.7%
RDG Read-Genezł3.1014.8%
BCX Bioceltixzł61.992.0%
BER Bioerg Spólka Akcyjnazł0.180.9%
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News



Pure Biologics Spólka Akcyjna